Literature DB >> 20508668

Hyponatremia: Prolonged use of the vasopressin antagonist tolvaptan is a safe and effective treatment for hyponatremia.

Rebecca Ireland.   

Abstract

Entities:  

Year:  2010        PMID: 20508668     DOI: 10.1038/nrneph.2010.61

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Oral tolvaptan is safe and effective in chronic hyponatremia.

Authors:  Tomas Berl; Friederike Quittnat-Pelletier; Joseph G Verbalis; Robert W Schrier; Daniel G Bichet; John Ouyang; Frank S Czerwiec
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

  1 in total
  1 in total

1.  Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan.

Authors:  Ramy M Hanna; Juan Carlos Velez; Anjay Rastogi; Minhtri K Nguyen; Mohammad K Kamgar; Kyaw Moe; Farid Arman; Huma Hasnain; Niloofar Nobakht; Umut Selamet; Ira Kurtz
Journal:  Kidney Med       Date:  2019-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.